Benjamin F. Edwards & Company’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
Benjamin F. Edwards & Company's ACLS Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its Axcelis (ACLS) stake by 85% in Q2 2024, selling an estimated $23.3K and leaving 36 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.
Benjamin F. Edwards & Company first reported a position in ACLS in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.32M in Q3 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.
- Benjamin F. Edwards & Company held 36 shares of Axcelis worth $5K as of Q2 2024.
- Benjamin F. Edwards & Company sold 202 Axcelis shares in Q2 2024, an estimated $23.3K.
- Axcelis made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1856 holding.
- Benjamin F. Edwards & Company first reported a position in Axcelis in Q3 2023 and has held it in 4 quarters since.
- Benjamin F. Edwards & Company's Axcelis position peaked at $1.32M in Q3 2023.
- 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.